← Back to Screener
Inspire Medical Systems, Inc. (INSP)
Price$56.97
Favorite Metrics
Price vs S&P 500 (26W)-33.55%
Price vs S&P 500 (4W)1.08%
Market Capitalization$1.64B
P/E Ratio (Annual)11.28x
All Metrics
P/CF (Annual)14.02x
Book Value / Share (Quarterly)$27.33
P/TBV (Annual)8.59x
Revenue Growth (3Y)30.76%
Cash Flow / Share (Quarterly)$2.75
Price vs S&P 500 (YTD)-42.16%
Gross Margin (TTM)85.39%
Net Profit Margin (TTM)15.95%
EPS (TTM)$4.97
10-Day Avg Trading Volume0.96M
EPS Excl Extra (TTM)$4.97
Revenue Growth (5Y)51.20%
EPS (Annual)$4.89
ROI (Annual)18.62%
Gross Margin (Annual)85.39%
Net Profit Margin (5Y Avg)-1.95%
Cash / Share (Quarterly)$10.79
P/E Basic Excl Extra (TTM)11.28x
Revenue Growth QoQ (YoY)12.25%
P/E Normalized (Annual)11.28x
ROA (Last FY)16.03%
Revenue Growth TTM (YoY)13.60%
EBITD / Share (TTM)$2.13
ROE (5Y Avg)-0.94%
Operating Margin (TTM)5.15%
Cash Flow / Share (Annual)$2.75
P/B Ratio2.10x
P/B Ratio (Quarterly)3.43x
Net Income / Employee (Annual)$0
EV / Revenue (TTM)1.68x
Net Interest Coverage (TTM)-20.00x
ROA (TTM)17.91%
EPS Growth QoQ (YoY)303.02%
EV / EBITDA (TTM)24.28x
EPS Incl Extra (Annual)$4.89
Current Ratio (Annual)6.08x
Quick Ratio (Quarterly)4.46x
3-Month Avg Trading Volume1.35M
52-Week Price Return-62.07%
EV / Free Cash Flow (Annual)19.57x
P/E Incl Extra (TTM)11.28x
Revenue / Employee (TTM)$1
Tangible BV / Share (Quarterly)$18.51
P/S Ratio (Annual)1.80x
Asset Turnover (Annual)1.01x
52-Week High$163.35
Operating Margin (5Y Avg)-5.12%
EPS Excl Extra (Annual)$4.89
CapEx CAGR (5Y)73.34%
Tangible BV CAGR (5Y)226.98%
26-Week Price Return-26.66%
Quick Ratio (Annual)4.46x
13-Week Price Return-40.95%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)6.08x
Enterprise Value$1,535.77
Revenue / Share Growth (5Y)47.29%
Asset Turnover (TTM)1.12x
Book Value / Share Growth (5Y)26.38%
Revenue / Employee (Annual)$1
Inventory Turnover (Annual)1.18x
Pretax Margin (Annual)7.20%
Cash / Share (Annual)$10.79
3-Month Return Std Dev64.05%
Gross Margin (5Y Avg)84.82%
Net Income / Employee (TTM)$0
ROE (Last FY)18.62%
Net Interest Coverage (Annual)-24.65x
EPS Basic Excl Extra (Annual)$4.89
P/FCF (TTM)16.42x
Receivables Turnover (TTM)8.57x
EV / Free Cash Flow (TTM)19.57x
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$4.97
Receivables Turnover (Annual)8.57x
ROI (TTM)21.07%
P/S Ratio (TTM)1.80x
Pretax Margin (5Y Avg)-3.51%
Revenue / Share (Annual)$30.65
Tangible BV / Share (Annual)$17.10
Forward P/E30.58x
Price vs S&P 500 (52W)-96.71%
P/E Ratio (TTM)11.28x
EPS Growth TTM (YoY)185.05%
Year-to-Date Return-38.23%
5-Day Price Return0.25%
EPS Normalized (Annual)$4.89
ROA (5Y Avg)-0.53%
Net Profit Margin (Annual)15.95%
Month-to-Date Return10.45%
Cash Flow / Share (TTM)$-1.03
EBITD / Share (Annual)$2.13
Operating Margin (Annual)5.15%
LT Debt / Equity (Annual)0.00x
P/CF (TTM)14.02x
ROI (5Y Avg)-0.58%
P/E Excl Extra (TTM)11.28x
LT Debt / Equity (Quarterly)0.00x
EPS Basic Excl Extra (TTM)$4.97
P/TBV (Quarterly)7.83x
P/B Ratio (Annual)3.43x
Inventory Turnover (TTM)1.18x
Pretax Margin (TTM)7.20%
Book Value / Share (Annual)$27.33
Price vs S&P 500 (13W)-43.33%
Beta0.83x
P/FCF (Annual)20.91x
Revenue / Share (TTM)$31.22
ROE (TTM)21.07%
52-Week Low$48.30
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.00
3.84
3.68
3.60
Industry Peers — Surgical & Medical Instruments(108)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
INSPInspire Medical Systems, Inc. | 1.80x | 51.20% | 85.39% | 5.15% | $56.97 |
SYKStryker Corporation | 5.17x | 11.84% | 64.57% | 19.43% | $338.34 |
BSXBoston Scientific Corp. | 4.58x | 15.16% | 69.01% | 18.00% | $60.99 |
MMM3M Company | 3.21x | -4.97% | 39.92% | 18.55% | $151.40 |
MDLNMedline Inc. Class A common stock | 2.20x | — | 26.44% | 7.78% | $48.26 |
BDXBecton, Dickinson and Co. | 2.06x | 6.32% | 46.42% | 12.15% | $158.64 |
RMDResMed Inc. | 6.07x | 11.72% | 60.85% | 33.70% | $226.14 |
DXCMDexCom, Inc. | 5.33x | 19.33% | 62.09% | 19.56% | $64.62 |
WSTWest Pharmaceutical Services, Inc. | 6.29x | 7.44% | 35.91% | 19.03% | $278.00 |
PODDInsulet Corporation | 5.19x | 24.53% | 71.63% | 12.92% | $200.87 |
PENPenumbra, Inc. | 9.24x | 20.16% | 67.14% | 13.48% | $329.71 |
About
Inspire Medical Systems develops and commercializes the Inspire system, a minimally invasive neurostimulation technology for treating moderate to severe obstructive sleep apnea. The company distributes its product through hospitals and ambulatory surgery centers, with the majority of revenue derived from the United States market and growing operations in Europe and the Asia Pacific region.